期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Immunomodulatory effect of pachymaran on cyclosporine A(CsA)-induced lung injury in mice 被引量:7
1
作者 CHEN Kaiqin WEI Ke +4 位作者 YE Chun ZHAO Tianhao ZHANG Bo XIAO Rong LU Fangguo 《Digital Chinese Medicine》 2022年第2期222-232,共11页
Objective To investigate the immunomodulatory effect of pachymaran on cyclosporine A(CsA)-induced lung injury in mice.Methods(i) Fifty male BALB/c mice were randomly divided into five groups(10 mice in each group): no... Objective To investigate the immunomodulatory effect of pachymaran on cyclosporine A(CsA)-induced lung injury in mice.Methods(i) Fifty male BALB/c mice were randomly divided into five groups(10 mice in each group): normal control(NC) group, 30, 45, and 60 mg/kg CsA groups, and lipopolysaccharide(LPS) group. Except for the NC group, other groups underwent CsA modeling. The NC group was treated with phosphate-buffered saline(PBS), the LPS group with 10 mg/kg LPS eight hours before mice euthanized, and the 30, 45, and 60 mg/kg CsA groups with corresponding doses of CsA for seven consecutive days. After treatment, the body and organ mass of each group were weighed, and the lung, thymus, and spleen indexes were calculated. Hematoxylin-Eosin(HE) staining was performed to observe histopathological changes in the lungs of the mice. The protein expression levels of interleukin(IL)-2 and IL-1β in the blood were detected using enzyme-linked immunosorbent assay(ELISA), and those of surfactant protein D(SP-D), IL-2, and IL-6 in lung tissues were detected by immunohistochemistry(IHC). The mRNA expression levels of SP-D, IL-1β, IL-6, and myeloperoxidase(MPO) in the lung tissues were detected by quantitative reverse transcriptase-polymerase chain reaction(q RT-PCR).(ii) Another 60 BALB/c mice were divided into six groups(10 mice in each group) : NC group,model control(MC) group, 50, 100, and 200 mg/kg pachymaran groups, and polyinosinicpolycytidylic acid [poly(I:C)] group. Except for the NC group, other groups underwent45 mg/kg CsA modeling. The NC and MC groups were treated with distilled water, the pachymaran groups with corresponding doses pachymaran, and the poly(I:C) group with 0.1 mg/kg poly(I:C) for seven days.The mice were euthanized to obtain tissues and serum for detection.Detection methods were identical to those described in(i) above.Results(i) CsA(30 mg/kg) increased the lung index of mice(P < 0.001), and decreased the spleen index(P < 0.01), thymus index(P < 0.05), and the serum level of IL-2(P < 0.05). CsA(45 mg/kg) decreased the spleen, thymus indexes, and the serum level of IL-2(P < 0.01) in mice, and increased the serum level of IL-1β(P < 0.05) and the protein level of lung SP-D(P <0.001). CsA(60 mg/kg) increased the lung index of mice(P < 0.01), the serum level of IL-1β(P < 0.05), the protein level of lung SP-D(P < 0.01), and the mRNA levels of lung MPO and SP-D( P < 0.05), and decreased the thymus index of mice(P < 0.01). HE staining showed that 30, 45, and60 mg/kg CsA, and LPS caused pathological changes in the lung tissue of mice.(ii) After pachymaran intervention in MC mice, the spleen and thymus indexes(P < 0.05) were increased in the 100 and 200 mg/kg pachymaran groups, and the lung index was decreased(P < 0.05).Moreover, 50 mg/kg pachymaran increased the thymus index(P < 0.05) and decreased the lung index(P < 0.01) in MC group. Pachymaran(50, 100, and 200 mg/kg) improved lung tissue injury, reduced the serum level of IL-1β(P < 0.001), and the mRNA levels of MPO and SPD in lung tissues(P < 0.05) of mice. Pachymaran(100 mg/kg) increased the protein level of lung IL-2(P < 0.01), decreased the protein level of lung SP-D(P < 0.01), and the mRNA level of IL-1β(P < 0.001) in the lung tissues of mice. Pachymaran(200 mg/kg) increased the serum level of IL-2(P < 0.01) and lung IL-6 of mice(P < 0.05). Pachymaran(50 and 200 mg/kg) increased the mRNA level of IL-6 in the lung tissues of mice(P < 0.05).Conclusion While the immune function of mice was suppressed by CsA, the lung tissue was also damaged. Pachymaran can improve the immunosuppression induced by CsA and improve the lung tissue injury in immunosuppressed mice. 展开更多
关键词 Cyclosporine A(CsA) IMMUNOSUPPRESSION Lung injury IMMUNOREGULATION Lipopolysaccharide(LPS) Pachymaran Polyinosinic-polycytidylic acid[poly(I:C)]
下载PDF
Poly(I:C)与R848对大鼠脊髓小胶质细胞活性的影响
2
作者 苏艳华 张志明 +1 位作者 张智仁 赵本华 《中华神经医学杂志》 CAS CSCD 北大核心 2009年第8期764-768,共5页
目的研究Toll样受体3(TLR3)配体多聚肌胞苷酸[Poly(I:C)]与TLR7/8配体R848对小胶质细胞(MG)活性的影响。方法6~8周龄Lewis大鼠30只分为Poly(I:C)组(12只)、R848组(15只)和对照组(3只),前两组大鼠根据处死时间的不同... 目的研究Toll样受体3(TLR3)配体多聚肌胞苷酸[Poly(I:C)]与TLR7/8配体R848对小胶质细胞(MG)活性的影响。方法6~8周龄Lewis大鼠30只分为Poly(I:C)组(12只)、R848组(15只)和对照组(3只),前两组大鼠根据处死时间的不同分别分为4、5个亚组,每亚组3只,分别单次腹腔注射1mLPoly(I:C)(5mg/kg)和R848(1mg/kg),对照组注射等量PBS;应用免疫组化检测大鼠脊髓内ED-1、同种异体移植炎性因子-1(AIF-1)、血管内皮单核细胞活化肽Ⅱ(EMAPⅡ)、OX-6和P2X4R的表达,应用免疫组化双染染色检测增殖的MG。结果与对照组相比,Poly(I:C)组和R848组注药后第4天ED-1^+的MG明显增加,差异有统计学意义(P〈0.05),Poly(I:C)组与R848组仅观察到少量EMAPⅡ^+细胞,未观察到AIF-1^+、OX6^+、P2X4R^+细胞,对照组未观察到EMAPII^+、AIF-1^+、OX6^+及P2X4R^+细胞:免疫组化双染显示Poly(I:C)组和R848组大鼠注射后第4天脊髓有少量BrdU^+/ED-1^+双染细胞,提示仅有少量MG增殖。结论TLR配体外周给药后可作用于脊髓内的固有免疫系统,进而影响脊髓内MG的免疫活性,提示这类制剂对调节脊髓损伤组织的再生修复有一定价值。 展开更多
关键词 多聚肌胞苷酸 R848 小胶质细胞 脊髓
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部